Stevanato Group S.p.A. (NYSE: STVN) Stock Analysis & Fundamentals

STVNStevanato Group S.p.A.

NYSE · US · Healthcare · Medical Instruments & Supplies · stevanatogroup.com

22.35USDMkt Cap: 6.10B $P/E: 39.211d ago

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South A…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$142.49BUSDP/E 45.6

EssilorLuxottica Societe anonyme

$80.53BUSDP/E 30.2

BDX

Becton, Dickinson and Company

$51.10BUSDP/E 32.5

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.90BUSDP/E 45.4

DIM

Sartorius Stedim Biotech

$20.62BUSDP/E 64.6

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

Solventum Corporation

$15.08BUSDP/E 10.8

COO

The Cooper Companies, Inc.

$14.85BUSDP/E 64.5

BAX

Baxter International Inc.

$13.77BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap6.10B $

Enterprise Value6.47B $

Revenue (TTM)1.23B $

Gross Profit343.88M $

Net Income (TTM)139.84M $

Revenue/Share4.488 USD

Last Price22.35 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees6.0K

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)39.21

P/E (Forward)26.60

PEG0.37

EV/EBITDA21.65

EV/Revenue5.28

P/S4.98

P/B3.41

EPS (TTM)0.58

EPS (Forward)0.84

52W Range

21.7594% of range22.39

52W High22.39 USD

52W Low21.75 USD

Profitability

Gross Margin28.99%

Oper. Margin17.22%

EBITDA Margin24.39%

Profit Margin11.79%

ROE9.41%

ROA5.50%

Growth

Revenue Growth7.80%

Earnings Growth-26.50%

Cash Flow & Leverage

Operating CF286.08M $

CapEx (TTM)275.03M $

FCF Margin-8.55%

FCF Yield-1.72%

Net Debt366.16M $

Net Debt/EBITDA1.23

Balance Sheet

Debt/Equity0.32

Current Ratio1.61

Quick Ratio1.08

Book Value/Sh6.564 USD

Cash/Share0.2900 USD

Dividends

Fwd Div Rate0.0600 USD

Trail. Div Rate0.0000 USD

Div. Yield0.28%

5Y Avg Yield—

Payout Ratio11.02%

Ex-Div DateJun 11, 2026

Pay DateJul 29, 2026

Analyst Consensus

Rating1.7 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)24.83 USD

Upside (mean)+11.1%

Target Range20.00 USD – 32.00 USD

$20.00+11.1% to mean$32.00

# Analysts11

Ownership

Shares Out.49.71M

Float49.03M

Insiders1.64%

Institutions97.14%

Short Interest

Short Ratio3.0d

Short % Float1.84%

Short % Out.0.33%

Shares Short903.12K

Short (prev mo.)946.39K

Technical

SMA 5019.21 (+16.4%)

SMA 20018.46 (+21.1%)

Beta0.74

S&P 52W Chg21.00%

Avg Vol (30d)298.30K

Avg Vol (10d)478.08K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—